[Brucella melitensis bacteremia with multiple organ involvement after laboratory contamination] [0.03%]
实验污染所致布鲁氏菌病并发器官功能损害病例报告
C Baugé,A de Pontfarcy,C Flateau et al.
C Baugé et al.
Z Zhao,J Xie,M Yin et al.
Z Zhao et al.
•Twenty-four out of 75 patients developed into severe condition in the course of the infection.•The prominent laboratory abnormalities of COVID patients were lymphopenia, elevated C-reactive protein (CRP) and lactate dehydrogenase (LDH)....
Haemophilus spp., an emerging multidrug-resistant sexually transmitted pathogen [0.03%]
嗜血杆菌属：一种新兴的多重耐药性性传播病原体
M Ducours,M Puges,A Desclaux et al.
M Ducours et al.
Objectives: To describe the characteristics of patients with a positive urethral sample for Haemophilus spp. Material and methods: We p...
COVID reverse transcriptase PCR in private laboratories: From theory to reality [0.03%]
私营实验室开展新冠病毒核酸检测业务：从理论到实践
M Autissier,G Guiraud,Y Lévy
M Autissier
Multicenter Study
Medecine et maladies infectieuses. 2020 Oct;50(7):627-629. DOI:10.1016/j.medmal.2020.06.001 2020
Serratia marcescens outbreak in the intensive care unit during the COVID-19 pandemic: A paradoxical risk? [0.03%]
新冠肺炎流行期间重症监护病房苏云金芽孢杆菌暴发：一种矛盾的风险吗？
R Amarsy,G R Pean de Ponfilly,H A Benmansour et al.
R Amarsy et al.
S Humbert,J Razanamahery,C Payet-Revest et al.
S Humbert et al.
Guidelines for the management of accidental exposure to Brucella in a country with no case of brucellosis in ruminant animals [0.03%]
人类偶然暴露于布鲁氏菌的管理指南：无牛羊布病疫情国家的建议措施
J P Stahl,J P Bru,J F Gehanno et al.
J P Stahl et al.
Erratum to "Management and prevention of imported malaria in children. Update of the French guidelines" [Med Mal Infect 50 (2020) 127-140] [0.03%]
“儿童疟疾的管理与预防（法国指南更新）”一文的勘误通知（卷50，期2，2020年，页127-140，页码S0399-077X(20)30026-X（DOI:10.1016/j.medmal.2020.02.005））
C Leblanc,C Vasse,P Minodier et al.
C Leblanc et al.
Published Erratum
Medecine et maladies infectieuses. 2020 Aug;50(5):396. DOI:10.1016/j.medmal.2020.04.014 2020
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients [0.03%]
托珠单抗治疗可减少COVID-19患者的重症监护住院和/或死亡风险
T Klopfenstein,S Zayet,A Lohse et al.
T Klopfenstein et al.
Introduction: No therapy has yet proven effective in COVID-19. Tocilizumab (TCZ) in patients with severe COVID-19 could be an effective treatment. Method:...